Quotables
"It is my heart-warmed and world-embracing Christmas hope and aspiration that all of us, the high, the low, the rich, the poor, the admired, the despised, the loved, the hated, the civilized, the savage (every man and brother of us all throughout the whole earth), may eventually be gathered together in a heaven of everlasting rest and peace and bliss, except the inventor of the telephone. "
Mark Twain ; Christmas greetings, 1890
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120128767 | THERAPEUTIC CALCIUM PHOSPHATE PARTICLES AND METHODS OF MAKING AND USING SAME The present invention provides novel calcium phosphate nanoparticles suitable for efficient encapsulation of biologically active molecules. The invention further provides pharmaceutical compositions comprising these nanoparticles, as well as methods of making such nanop... | 05/24/2012 |
| 20120128770 | TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE The present invention relates to 1 or 2 C16-C18 acyl glycerol based compounds which are capable of activating G-protein coupled receptor 119 and thereby stimulate GLP-1 release. Compounds of the present invention are useful in the prophylaxis and/or treatment of metabol... | 05/24/2012 |
| 20120082720 | Compositions For Treating Chronic Viral Infections The present invention describes dietary compositions and methods of using such compositions to treat chronic viral infections, including hepatitis B and hepatitis C infections.... | 04/05/2012 |
| 20120082721 | Enteric coating The present invention refers to a dosage form comprising an enteric coating in a specific amount, and to the use of enteric coating compositions for preparing a dosage form. Furthermore, the present invention also relates to a process for the preparation of a solid oral... | 04/05/2012 |
| 20120045509 | MODIFIED RELEASE COMPOSITIONS FOR DPP-IV INHIBITORS The present invention refers to pharmaceutical composition comprising a DPP-IV inhibitor.... | 02/23/2012 |
| 20120034299 | COMPOSITIONS FOR THE TREATMENT OF GLUTEN INTOLERANCE AND USES THEREOF The present invention provides compositions for use in the prophylaxis or treatment of a condition arising from gluten intolerance, the compositions including at least partially purified caricain (or a biologically active fragment, analogue or variant thereof) alone or ... | 02/09/2012 |
| 20120027864 | COATED DRUG DELIVERY FORMULATIONS The invention relates generally to methods of making formulations for delivering biological agents to a patient. In one aspect, proliposomal drug-delivery systems for medicaments are provided. In another aspect, coated proliposomal formulations for poorly water soluble ... | 02/02/2012 |
| 20120009256 | Treatment Including Prebiotic Composition for use with Probiotics Naturally occurring lecithins and/or oleic acid stimulate the growth and lactic acid producing activity of Lactobacillus and Bifidobacterium species of probiotic bacteria, and replace polysorbate 80 for those products. They can be used in naturally occurri... | 01/12/2012 |
| 20120003307 | LEVETIRACETAM CONTROLLED RELEASE COMPOSITION The present invention is concerned with controlled release compositions for oral administration comprising levetiracetam; and with processes of preparing such controlled release compositions.... | 01/05/2012 |
| 20110311622 | METHOD FOR ADDING SENSORY CONDITIONING CUES IN A PHARMACOTHERAPEUTIC REGIMEN A method for administering pharmaceutical agents to a subject is provided. The method includes the steps of: a) providing a course of treatment for a subject, which course includes periodically administering an amount of medicine to the subject, which amount of medicine... | 12/22/2011 |
| 20110311621 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF DELVERY The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent (such as CCK-8, octreotide), at least one salt of a medium chain fatty acid, a matrix forming po... | 12/22/2011 |
| 20110305755 | METHOD OF ADDING BOTANICAL AGENTS/DIETARY SUPPLEMENTS TO PHARMACEUTICAL AGENTS IN A PHARMACOTHERAPEUTIC REGIMEN A method for administering an active pharmaceutical agent (APA) is provided that includes the steps of: a) providing a medicine having a dose of at least one APA and at least one active botanical agent (ABA) or dietary supplement; and b) dosing the APA within the medici... | 12/15/2011 |
| 20110300213 | Oral formulations of bipolar trans carotenoids The subject invention relates to a variety of formulations of bipolar trans carotenoids including pharmaceutical compositions for oral delivery of a bipolar trans carotenoid comprising i) a bipolar trans carotenoid, ii) a cyclodextrin, and iii) a coating. The invention ... | 12/08/2011 |
| 20110274750 | ENTERIC FORMULATION OF DULOXETINE AND ITS CORE AND PREPRATION METHOD An enteric formulation of duloxetine, its core and preparing method thereof are disclosed. The core comprises duloxetine or its salt and pharmaceutically acceptable excipients. The excipients include water-soluble hot melt materials selected from PEG, poloxamer, polyoxy... | 11/10/2011 |
| 20110268792 | SURFACE ACTIVE PROTEINS AS EXCIPIENTS IN SOLID PHARMACEUTICAL FORMULATIONS The invention relates to a use of surface active hydrophobins for applications in pharmaceutical technology, in particular as excipients for galenic use. Provided is a method for either admixture of hydrophobins to galenic compositions or for treating the surface of pha... | 11/03/2011 |
| 20110244038 | BERRY PREPARATIONS AND EXTRACTS Compositions having antioxidant and anti-inflammatory activity, and methods for providing such compositions, are disclosed. In one aspect, the compositions are derived by exposing a berry to an acidic solvent composition, adding a cryoprotectant, and recovering a berry ... | 10/06/2011 |
| 20110229564 | Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof The present invention relates provides pharmaceutical compositions comprising an amorphous carvedilol salt and one or more pharmaceutically acceptable excipients, wherein the amorphous carvedilol salt is formed in situ during the preparation of the pharmaceutical compos... | 09/22/2011 |
| 20110223248 | METHODS AND COMPOSITIONS FOR TREATING LACTOSE INTOLERANCE The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasin... | 09/15/2011 |
| 20110206764 | FORMULATIONS FOR ENHANCED BIOAVAILABILITY OF ORALLY ADMINISTERED POLAR AGENTS A composition is described having improved oral permeability of polar agents such as neuraminidase inhibitors. The composition includes one or more polar agents and one or more permeability enhancers such that the composition increases the amount of the polar agent capa... | 08/25/2011 |
| 20110206765 | Non-Typeable Haemophilus Influenzae Vaccines and Their Uses Provided are non-typeable Haemophilus influenzae vaccines useful for the treatment of chronic obstructive pulmonary disease and asthma in a patient. In certain aspects, the vaccine is a monobacterial vaccine. Bacterial strains for use in the vaccines of the prese... | 08/25/2011 |
| 20110182986 | CONTROLLED RELEASE COMPOSITION An improved composition for controlling the release profile of an active compound through the intestinal tract comprises particles, especially pellets, containing the active compound, which are coated with a pH dissolution dependent coating material or a polymethacrylat... | 07/28/2011 |
| 20110171281 | SOFT CAPSULE COMPOSITION AND METHOD OF USE A clear soft vegetarian dosage capsule comprising a first and second biphasic film. The first biphasic film has a plurality of first reservoirs and further comprises a polysaccharide, a seaweed extract, a rheology modifier, a buffer and a plasticizer. The second biphasi... | 07/14/2011 |
| 20110165231 | Treatment of Fructose Malabsorption The present invention relates to the composition comprising crystalline xylose-isomerase (EC 5.3.1.5) and at least one salt of a metal and/or alkaline earth metal.... | 07/07/2011 |
| 20110159083 | Nanoparticles for protein drug delivery The invention discloses nanoparticles composed of chitosan, poly-glutamic acid, and at least one bioactive agent characterized with a positive surface charge. The bioactive agent is hydrophobic or lipophilic in nature and is associated with micelles before being encapsu... | 06/30/2011 |
| 20110159090 | ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier layer, wherein the diffusion layer is bonded to the barrier layer and comprise... | 06/30/2011 |
| 20110150992 | QUININE FORMULATIONS, METHOD OF MAKING, AND METHOD OF USE THEREOF Disclosed herein are quinine formulations and methods of using quinine formulations. Specifically disclosed herein are solid oral dosage forms which can be administered as a capsule or tablet, or alternatively as a sprinkle form with the patient experiencing little or n... | 06/23/2011 |
| 20110150970 | ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier layer, wherein the diffusion layer is bonded to the barrier layer and comprise... | 06/23/2011 |
| 20110150969 | ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier layer, wherein the diffusion layer is bonded to the barrier layer and comprise... | 06/23/2011 |
| 20110142926 | Nanoparticles for protein drug delivery The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one antibiotics or equivalent bioactive agent characterized with a positive surface charge and their enhanced permeability in oral drug delivery.... | 06/16/2011 |
| 20110142927 | Nanoparticles for protein drug delivery The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one anti-hemophilic factor or bioactive agent characterized with a positive surface charge and their enhanced permeability in oral drug delivery.... | 06/16/2011 |
| 20110125079 | Echogenic Polymer Microcapsules and Nanocapsules and Methods for Production and Use Thereof Methods for producing echogenic polymer microcapsules and nanocapsules for use in diagnostic imaging and delivery of bioactive compounds as well as targeted imaging and delivery to selected tissues and cells are provided. Compositions containing these echogenic polymer ... | 05/26/2011 |
| 20110123614 | Oral Dosage Forms for Delivery of Therapeutic Agents Oral dosage forms for the delivery of therapeutic agents include mechanical fasteners for engaging tissue of the gastrointestinal tract.... | 05/26/2011 |
| 20110111023 | PREVENTION OF TYPE 1 DIABETES BY ADMINISTRATION OF GLIADIN The invention herein is related to intranasal or other mucosal administration of gliadin, or parts thereof, to prevent the development of type 1 diabetes. This environmental antigen, which may have etiological role in the development of diabetes in genetically predispos... | 05/12/2011 |
| 20110111020 | Microcapsules Having Multiple Shells and Method for the Preparation Thereof Single-core and multi-core microcapsules are provided, having multiple shells, at least one of which is formed of a complex coacervate of two components of shell materials. The complex coacervate may be the same or different for each shell. Also provided are methods for... | 05/12/2011 |
| 20110104218 | METHODS AND COMPOSITIONS FOR PRODUCING HYDROGEL CAPSULES COATED FOR LOW PERMEABILITY AND PHYSICAL INTEGRITY Methods and compositions for producing hydrogel capsules enveloped with at least one coating layer is disclosed. The coating formulations deposited on the surface of the capsules can improve the physical integrity and the water-retention properties of the alginate beads... | 05/05/2011 |
| 20110097399 | FAST DISSOLVING/DISINTEGRATING COATING COMPOSITIONS A pharmaceutical composition for oral administration comprising a core and a film coating on the core that exhibits enhanced disintegration characteristics is disclosed. The film coating comprises a film forming polymer, an organic solvent, a super-disintegrant and, opt... | 04/28/2011 |
| 20110091540 | POLYMERIC COMPOSITIONS AND THEIR METHOD OF USE IN COMBINATION WITH ACTIVE AGENTS A combination of active agents is disclosed which are particularly useful for treating fluid overload conditions. Methods for using the combination of active agent are also disclosed. The combination can include a highly absorbent polyelectrolyte polymer along with an a... | 04/21/2011 |
| 20110091543 | ORAL DELIVERY OF MODIFIED TRANSFERRIN FUSION PROTEINS Pharmaceutical compositions containing modified fusion proteins of transferrin and therapeutic proteins or peptides with increased serum half-life or increased serum stability are disclosed. Preferred fusion proteins include those modified so that the transferrin moiety... | 04/21/2011 |
| 20110086095 | Bioadhesive Polymers Polymers and compositions, collectively “bioadhesive materials”, with improved bioadhesive properties have been developed. One or more compounds comprising: a) an aromatic moiety comprising two or more hydroxyl substituents, methoxy substituents, substituents hydrol... | 04/14/2011 |
| 20110081413 | Pharmaceutical Compositions Comprising Phosphate-Binding Polymer The present invention discloses pharmaceutical composition comprising phosphate binding polymers such as Sevelamer carbonate substantially free of monovalent anion other than bicarbonate anion. Particularly, monovalent anion content is less than about 0.05% (w/w). Discl... | 04/07/2011 |
